Stay updated with breaking news from Nasdaq Ctic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) was the target of a large increase in short interest in May. As of May 31st, there was short interest totalling 11,270,000 shares, an increase of 39.5% from the May 15th total of 8,080,000 shares. Based on an average trading volume of 5,510,000 shares, the short-interest ratio is […]
CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) was the target of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 11,270,000 shares, an increase of 39.5% from the May 15th total of 8,080,000 shares. Based on an average daily trading volume, of 5,510,000 shares, […]
StockNews.com initiated coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a research report report published on Saturday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other research firms also recently weighed in on CTIC. TD Cowen dropped their price target on shares of CTI BioPharma from […]
CTI BioPharma (NASDAQ: CTIC) recently received a number of ratings updates from brokerages and research firms: 5/26/2023 – CTI BioPharma is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 5/18/2023 – CTI BioPharma is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 5/16/2023 […]
StockNews.com assumed coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a report published on Friday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other analysts have also recently issued reports on CTIC. Needham & Company LLC cut CTI BioPharma from a buy rating to a hold […]